The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...

Tenpoint Therapeutics’ Yuvezzi gets US FDA nod; the first and only combo eye drop approved to treat presbyopia: London Saturday, January 31, 2026, 14:00 Hrs [IST] Tenpoint Thera ...

(Gray News) - Several eye care products used to treat dry and irritated eyes are being voluntarily recalled. According to AvKARE, a pharmaceutical manufacturer, it has issued a recall following an ...

Credit: Alcon. Access initiatives including a First Fill Free trial program and an ongoing copay support will be available for eligible patients. The active ingredient in Tryptyr is acoltremon, an ...

Tens of thousands of cases of eye drops have been recalled by BRS Analytical Services. The recall was initiated on April 23, but the Food and Drug Administration listed it as a Class II on May 6, ...